Is your company a mature Scale-up or SME with a cutting edge or innovative product/service in the medtech, biotech or digital health sectors?
What will you get? We’ll provide you insider knowledge and support for a soft-landing in the 2ND LARGEST AND FASTEST GROWING E-HEALTH ECOSYSTEM in the world
EXPLORE market opportunities
- Expand in the No1. Hi-tech reform city
(Singapore modell), innovative Shenzhen region acting as acceleration base camp
- Mega City: 50 million+
(incl. Hong Kong as premium international finance centre)
young and ambitious population (average age 28)
PARTNERING UP and technology sourcing, manufacturing cooperation, access to distribution networks, government institutions, reliability & quality assurance
- Strong hi-tech network in China access to other regions
- Hosts over 270 of World’s Global 500 enterprises
- Leader in the medical devices sector + gene sequencing industry
- (BGI- No1. genomics organisation)
ACCESS TO ADDITIONAL CAPITAL to fuel China expansion with Chinese investors OR co-investors to strengthen existing EU investments so you can expand internationally with a complementary programme addressing Shenzhen in China (and Hong Kong) regions.
- 1/3 of all Chinese VC firms; strong exit environment
- 100x increase: China’s SME Board (similar role to Nasdaq)
- R&D&I represented 4.05% of GDP (2015); 13,300 PCT international patents filed in 2015, 46.9% of the total number filed across all of China (!) – strong IPR culture;
- Highest GDP per capita in China, tear one location